"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.
Uppsala University Hospital First in Sweden to Treat Patient With Elekta Unity Cancer Treatment System
Elekta President and CEO, Richard Hausmann, said: "We are very excited that Uppsala University Hospital, as the first clinic in Sweden, has joined the growing number of cancer clinics around the world providing precision radiation medicine to their patients using the most advanced technology."
2/4/19: Information gained through the MOMENTUM study will guide the use of MR/RT to improve outcomes for cancer patients.
6/18/18: New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized cancer treatment.
4/12/18: With new initiatives in 2018, Elekta is poised to transform the delivery of radiation therapy and the oncology data ecosystem for patient-specific care paths
Elekta's Leksell Gamma Knife® Icon™ radiosurgery system has received clearance from the China Food and Drug Administration (CFDA), enabling health care providers in the country to offer this advanced technology to their patients. With stereotactic imaging, automatic delivery correction and dose evaluation for ultra-precise dose delivery, as well as the availability of frameless treatments, Icon is capable of treating virtually any target in the brain, regardless of type, location or volume.